Comments
yourfanat wrote: I am using another tool for Oracle developers - dbForge Studio for Oracle. This IDE has lots of usefull features, among them: oracle designer, code competion and formatter, query builder, debugger, profiler, erxport/import, reports and many others. The latest version supports Oracle 12C. More information here.

2008 West
DIAMOND SPONSOR:
Data Direct
SOA, WOA and Cloud Computing: The New Frontier for Data Services
PLATINUM SPONSORS:
Red Hat
The Opening of Virtualization
GOLD SPONSORS:
Appsense
User Environment Management – The Third Layer of the Desktop
Cordys
Cloud Computing for Business Agility
EMC
CMIS: A Multi-Vendor Proposal for a Service-Based Content Management Interoperability Standard
Freedom OSS
Practical SOA” Max Yankelevich
Intel
Architecting an Enterprise Service Router (ESR) – A Cost-Effective Way to Scale SOA Across the Enterprise
Sensedia
Return on Assests: Bringing Visibility to your SOA Strategy
Symantec
Managing Hybrid Endpoint Environments
VMWare
Game-Changing Technology for Enterprise Clouds and Applications
Click For 2008 West
Event Webcasts

2008 West
PLATINUM SPONSORS:
Appcelerator
Get ‘Rich’ Quick: Rapid Prototyping for RIA with ZERO Server Code
Keynote Systems
Designing for and Managing Performance in the New Frontier of Rich Internet Applications
GOLD SPONSORS:
ICEsoft
How Can AJAX Improve Homeland Security?
Isomorphic
Beyond Widgets: What a RIA Platform Should Offer
Oracle
REAs: Rich Enterprise Applications
Click For 2008 Event Webcasts
SYS-CON.TV
Today's Top SOA Links


CRC Health Group Opiate Treatment Outcomes Show Pharmaeconomic Benefit With Non-Injectable Form of Naltrexone
Data Presented at American Academy of Addiction Psychiatry Annual Meeting Indicate Lowered AMA Rates, Longer LOS & Fewer Readmissions, Promising Implications for Treatment & Managed Care Policy

CUPERTINO, CA -- (Marketwire) -- 01/16/13 -- The results from a pilot evaluation of a once-monthly, extended-release naltrexone injectable for opiate addiction conducted by CRC Health Group, the largest behavioral health care company in the U.S., serving over 29,000 opioid dependents daily, provide promising implications for the treatment industry and managed care policy: lower rates of discharge against medical advice (AMA), longer lengths of stay in treatment (retention), and fewer readmissions (relapse).

The data were presented recently at the American Academy of Addiction Psychiatry (AAAP) Annual Meeting, and authored by Kathleen Brady, MD, PhD, of Medical University of South Carolina, Philip L. Herschman, PhD, of CRC Health Group, Gerald Shulman, MA, MAC, of Shulman & Associates, and David R. Gastfriend, MD, of Alkermes, Inc.

The multi-site, retrospective pilot study analyzed the electronic records of 8,441 patients from CRC Health Group residential facilities over the course of 12 months. CRC developed a specialized program called "Provita" to treat opioid dependence by combining counseling services with Vivitrol®, the once-monthly, non-narcotic, non-addictive injectable form of naltrexone developed by Alkermes. Vivitrol® blocks the reception of opioids to the relevant brain receptor sites, thereby blocking the creation of dopamine (the "high") and reducing cravings.

After detoxification and during inpatient rehabilitation, the CRC patients fell into one of three groups: 1) not recommended for or prescribed the once-monthly injectable, 2) prescribed but did not receive the once-monthly injectable (due to insurance denial or other reasons), or 3) received the once-monthly injectable at least once during rehab.

Compared to patients who did not receive the once-monthly injectable during rehab, those patients who did had 85% lower AMA rates, 37% lower readmission rates, and a 37% increase of length of stay. More specifically, discharges against medical advice (AMA) occurred in 28% of those patients who did not receive the injectable, 25% of those who were prescribed but did not receive the injectable, and just 4% of those who did receive the injectable. Results were generally consistent across the CRC Health Group sites.

These results prompted a collaborative disease management initiative with a leading behavioral managed care organization. The goal, says CRC, is to align opioid dependence prior authorization with a model of integrated counseling services and the once-monthly injectable in California, South Dakota and Texas CRC facilities. The program involves early identification of patients at-risk for relapse and actively engages them in longitudinal treatment.

"The findings of this study, which are currently undergoing replication, have very promising implications for U.S. managed care policy, the treatment industry at-large and, most importantly, our patients," said Dr. Herschman, CRC Health Group's Chief Clinical Officer.

About CRC Health Group

CRC Health Group is the largest and most comprehensive network of specialized behavioral care services in the nation. CRC Health Group offers the largest array of personalized treatment options, allowing individuals, families, and professionals to choose the most appropriate treatment setting for their behavioral, addiction, weight management and therapeutic education needs. CRC is committed to making its services widely and easily available, while maintaining a passion for delivering advanced treatment. Since 1995, CRC programs have helped individuals and families reclaim and enrich their lives. For more information, visit www.crchealth.com.

Add to Digg Bookmark with del.icio.us Add to Newsvine

Christine Simmons
Shana Starr
LFPR (CRC Health Group)
949-502-6200 ext. 320 / 209
christines@lfpr.com
shanas@lfpr.com

About Marketwired .
Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.

Web 2.0 Latest News
More and more Web sites and applications are being moved from Apache to nginx. While Apache is still the number one HTTP server with more than 60% on active Web sites, nginx has now taken over the 2nd place in the ranking and relegated Microsoft’s IIS to 3rd place. Among the top 10.000...
Getting one's arms around the Internet of Things is a daunting task. In addition to big IoT commitments from all of the big players in computing and telco, there are a number of smaller companies and startups working on devices and services to enable the future of enterprise IT and per...
Let me think lemme think. Do I date myself unnecessarily by making a “Gaslight” reference? You know, the 1944 film with Ingrid Bergman and several other great actors in which the remote, seeming random dimming of a house's gaslights were part of a plot to convince Ingrid's character sh...
We're in an era of maturing cloud computing services, with lines beginning to blur among formerly discrete segments. Among the things we're witnessing is a fuller integration of DevOps into the mix. Rackspace is one company in this discussion, having just launched its DevOps Advisory S...
Earlier, I wrote a bit about traffic and the IoT. It's a big topic. The traffic problems of the developed and developing worlds seem so large, complex, and intractable to significant change in any reasonable timeframe. Consider Mexico City. There are more than 20 million people in ...
Subscribe to the World's Most Powerful Newsletters
Subscribe to Our Rss Feeds & Get Your SYS-CON News Live!
Click to Add our RSS Feeds to the Service of Your Choice:
Google Reader or Homepage Add to My Yahoo! Subscribe with Bloglines Subscribe in NewsGator Online
myFeedster Add to My AOL Subscribe in Rojo Add 'Hugg' to Newsburst from CNET News.com Kinja Digest View Additional SYS-CON Feeds
Publish Your Article! Please send it to editorial(at)sys-con.com!

Advertise on this site! Contact advertising(at)sys-con.com! 201 802-3021




SYS-CON Featured Whitepapers
ADS BY GOOGLE